About Transcription factor ETV6
Transcription factor ETV6 (ETV6) is a protein
from Homo sapiens identified by UniProt accession
P41212, 452 residues long.
MolForge cross-references it against 0 known binders and
515 disease associations.
Target properties
| Protein name | Transcription factor ETV6 |
| UniProt accession | P41212 |
| Gene | ETV6 |
| Organism | Homo sapiens |
| Length | 452 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (515)
Diseases linked to this target (Open Targets).
- thrombocytopenia 5 · score 0.77
- Thrombocytopenia · score 0.64
- acute myeloid leukemia · score 0.63
- cancer · score 0.60
- acute lymphoblastic leukemia · score 0.54
- T-cell acute lymphoblastic leukemia · score 0.51
- body height · score 0.49
- lean body mass · score 0.47
- genetic disorder · score 0.46
- hemoglobin measurement · score 0.45
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P41212-F1 | alphafold | PREDICTED | 61.80 | — |
Amino-acid sequence (452 residues)
MSETPAQCSI KQERISYTPP ESPVPSYASS TPLHVPVPRA LRMEEDSIRL PAHLRLQPIY WSRDDVAQWL KWAENEFSLR PIDSNTFEMN GKALLLLTKE DFRYRSPHSG DVLYELLQHI LKQRKPRILF SPFFHPGNSI HTQPEVILHQ NHEEDNCVQR TPRPSVDNVH HNPPTIELLH RSRSPITTNH RPSPDPEQRP LRSPLDNMIR RLSPAERAQG PRPHQENNHQ ESYPLSVSPM ENNHCPASSE SHPKPSSPRQ ESTRVIQLMP SPIMHPLILN PRHSVDFKQS RLSEDGLHRE GKPINLSHRE DLAYMNHIMV SVSPPEEHAM PIGRIADCRL LWDYVYQLLS DSRYENFIRW EDKESKIFRI VDPNGLARLW GNHKNRTNMT YEKMSRALRH YYKLNIIRKE PGQRLLFRFM KTPDEIMSGR TDRLEHLESQ ELDEQIYQED EC
Explore Transcription factor ETV6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets